Shahla Masood, M.D.

Shahla Masood M.D.

Professor & Chair, Department of Pathology and Laboratory Medicine; Program Director, Breast Pathology Fellowship; Medical Director, Breast Health Center; Program Director, Cytopathology Fellowship; Director of Research; Interim Director of Cancer Programs

Department: Department of Pathology and Laboratory Medicine
Business Phone: (904) 244-7815
Business Email: shahla.masood@jax.ufl.edu

Board Certifications

  • Pathology - Anatomic and Clinical
  • Cytopathology

Clinical Profile

Specialties
  • Cytopathology
  • Pathology - Anatomic and Clinical
Interests
  • Clinical Special Interests: Breast pathology, cytopathology
  • Research Special Interests: Early breast cancer detection; use of minimally invasive procedures to provide optimal samples for analysis; prognostic/predictive index

Publications

2022
Associations of Computed Tomography Image-Assessed Adiposity and Skeletal Muscles with Triple-Negative Breast Cancer.
Cancers.14(7):-[DOI] 10.3390/cancers14071846.[PMID] 35406618.
2022
Toward realization of remote controlled telecytopathology-a validation study from a large academic medical center from the southeast United States.
Journal of the American Society of Cytopathology.11(5):320-327[DOI] 10.1016/j.jasc.2022.04.003.[PMID] 35589507.
2021
Changing the philosophy, direction, and the governance of The Breast Journal as it moves towards becoming an "Open Access" journal in 2022.
The breast journal.27(1):5-6[DOI] 10.1111/tbj.14145.[PMID] 33368841.
2021
Farewell to The Breast Journal: A novel scientific publication led by a pathologist who moved beyond the microscope and faced the patients.
The breast journal.27(12):849-850[DOI] 10.1111/tbj.14304.[PMID] 34897874.
2021
Prediction and assessment of response to neo-adjuvant chemotherapy in breast cancer: The responsibilities of breast pathologists.
The breast journal.27(8):629-630[DOI] 10.1111/tbj.14274.[PMID] 34331376.
2021
The continued role of intraoperative assessment of the surgical margins in lumpectomy samples.
The breast journal.27(11):795-796[DOI] 10.1111/tbj.14298.[PMID] 34761478.
2021
The significance of accurate diagnosis of encapsulated papillary carcinoma of the breast by core needle biopsy.
The breast journal.27(3):207-208[DOI] 10.1111/tbj.14220.[PMID] 33723925.
2021
This is Not Only about the Biology: The Socioeconomic Disparities among African American Women with Breast Cancer Still Play a Significant Role.
The breast journal.27(7):571-572[DOI] 10.1111/tbj.14263.[PMID] 34145683.
2021
Why proper characterization of breast cancer subtypes makes a difference in patient care.
The breast journal.27(9):689-690[DOI] 10.1111/tbj.14285.[PMID] 34431163.
2021
Why women with an average risk for breast cancer undergo contralateral breast mastectomy? Does healthcare coverage matter?
The breast journal.27(10):743-745[DOI] 10.1111/tbj.14293.[PMID] 34582066.
2020
Breast cancer risk assessment and management.
The breast journal.26(8):1505-[DOI] 10.1111/tbj.14013.[PMID] 32783316.
2020
Breast cancer treatment: A phased approach to implementation.
Cancer.126 Suppl 10():2365-2378[DOI] 10.1002/cncr.32910.[PMID] 32348571.
2020
Breast pathology: The core of an integrated practice of personalized breast care.
The breast journal.26(6):1121-1122[DOI] 10.1111/tbj.13873.[PMID] 32372475.
2020
Celebrating a "Quarter of Century" contributions of The Breast Journal.
The breast journal.26(1):4-[DOI] 10.1111/tbj.13727.[PMID] 31957908.
2020
Is it ductal carcinoma in situ with microinvasion or "Ductogenesis"? The role of myoepithelial cell markers.
The breast journal.26(6):1138-1147[DOI] 10.1111/tbj.13897.[PMID] 32447817.
2020
Is it time to address the continuous dilemma of breast cancer disparities among African Americans? A call to action.
The breast journal.26(12):2339-2340[DOI] 10.1111/tbj.14124.[PMID] 33283942.
2020
The Breast Health Global Initiative 2018 Global Summit on Improving Breast Healthcare Through Resource-Stratified Phased Implementation: Methods and overview.
Cancer.126 Suppl 10():2339-2352[DOI] 10.1002/cncr.32891.[PMID] 32348573.
2020
The changing role of pathologists from morphologists to molecular pathologists in the era of precision medicine.
The breast journal.26(1):27-34[DOI] 10.1111/tbj.13728.[PMID] 31876097.
2020
The role of pathologists in recognition of morphologic and biologic features of genetically mutated breast cancer.
The breast journal.26(8):1583-1588[DOI] 10.1111/tbj.14012.[PMID] 32845077.
2020
Ultrastructural Characteristics of Gallbladder Epithelial Inclusions Mimicking Cystoisospora.
American journal of clinical pathology.153(1):88-93[DOI] 10.1093/ajcp/aqz137.[PMID] 31600399.
2019
Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations.
The breast journal.25(4):575-577[DOI] 10.1111/tbj.13292.[PMID] 31280501.
2016
Breast cancer subtypes: morphologic and biologic characterization.
Women's health (London, England).12(1):103-19[DOI] 10.2217/whe.15.99.[PMID] 26756229.
2016
DNA Methylation of the hTERT Gene in Breast Cancer Revisited: Diagnostic and Clinical Implications.
Laboratory medicine.47(4):293-299[DOI] .[PMID] 27708168.
2016
Moving toward appropriateness of breast cancer care: a balanced act to redefine the scope of standard of care.
Women's health (London, England).12(2):163-6[DOI] 10.2217/whe-2015-0002.[PMID] 26901376.
2016
Neoadjuvant chemotherapy in breast cancers.
Women's health (London, England).12(5):480-491[DOI] .[PMID] 27885165.
2016
The potential of identification of a malignancy-associated biomarker in breast cancer diagnosis and research: hTERT gene DNA methylation.
Diagnostic cytopathology.44(8):670-5[DOI] 10.1002/dc.23505.[PMID] 27229911.
2015
Comparative cost-effectiveness of fine needle aspiration biopsy versus image-guided biopsy, and open surgical biopsy in the evaluation of breast cancer in the era of Affordable Care Act: a changing landscape.
Diagnostic cytopathology.43(8):605-12[DOI] 10.1002/dc.23270.[PMID] 25722099.
2015
Cytologic features of metanephric adenoma of the kidney: case report and review of the literature.
Laboratory medicine.46(2):153-8; quiz e30[DOI] 10.1309/LMW2MHDM6EILGQH2.[PMID] 25918196.
2015
Development of a novel approach for breast cancer prediction and early detection using minimally invasive procedures and molecular analysis: how cytomorphology became a breast cancer risk predictor.
The breast journal.21(1):82-96[DOI] 10.1111/tbj.12362.[PMID] 25556774.
2015
Diagnostic value and accuracy of imprint cytology evaluation during image-guided core needle biopsies: Review of our experience at a large academic center.
Diagnostic cytopathology.43(10):773-9[DOI] 10.1002/dc.23300.[PMID] 26119885.
2015
Htert Gene Expression and Dna Methylation in Breast Cancer Revisited By Realtime Rt-Pcr and Methylation Specific Pcr
Laboratory Investigation.95(1):72A-73A[DOI] .[PMID] .
2015
Is digoxin a breast cancer risk factor?
Acute cardiac care.17(2):29-31[DOI] 10.3109/17482941.2015.1066823.[PMID] 26458027.
2015
Minimizing Errors in Breast Pathology: A Call for Action.
The breast journal.21(4):333-6[DOI] 10.1111/tbj.12440.[PMID] 26136182.
2014
Appropriateness of breast cancer care: a changing landscape focusing on proper utilization of resources and patients' choices.
The breast journal.20(1):1-2[DOI] 10.1111/tbj.12224.[PMID] 24438062.
2014
Htert Gene Dna Methylation Index and Breast Invasive Ductal Carcinoma
Laboratory Investigation.94(1):66A-67A[DOI] .[PMID] .
2013
Building access to quality breast pathology diagnosis across the globe: a call for action.
The breast journal.19(3):229-30[DOI] 10.1111/tbj.12120.[PMID] 23614362.
2013
Focusing on breast cancer overdiagnosis and overtreatment: the promise of molecular medicine.
The breast journal.19(2):127-9[DOI] 10.1111/tbj.12095.[PMID] 23458217.
2013
Ultrasound guided fine needle aspiration biopsy: the new challenges and opportunities for cytopathologists.
Diagnostic cytopathology.41(12):1017-8[DOI] 10.1002/dc.23057.[PMID] 24167040.
2012
Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotyping.
The breast journal.18(4):303-11[DOI] 10.1111/j.1524-4741.2012.01264.x.[PMID] 22759093.
2012
Changing the term "breast tumor resembling the tall cell variant of papillary thyroid carcinoma" to "tall cell variant of papillary breast carcinoma".
Advances in anatomic pathology.19(2):108-10[DOI] 10.1097/PAP.0b013e318249d090.[PMID] 22313838.
2012
Characteristics of systemic diseases in the breast: clinical, imaging and pathologic features.
Women's health (London, England).8(5):593-9[DOI] 10.2217/whe.12.45.[PMID] 22934732.
2012
Cytomorphology of male breast lesions: diagnostic pitfalls and clinical implications.
Diagnostic cytopathology.40(2):179-84[DOI] 10.1002/dc.21601.[PMID] 22246937.
2012
Expanded role of cytopathology in breast cancer diagnosis, therapy and research: the impact of fine needle aspiration biopsy and imprint cytology.
The breast journal.18(1):1-2[DOI] 10.1111/j.1524-4741.2011.01199.x.[PMID] 22226067.
2012
New insights from breast pathology: should we consider low grade DCIS NOT a cancer?
European journal of radiology.81 Suppl 1():S93-4[DOI] 10.1016/S0720-048X(12)70037-2.[PMID] 23083619.
2012
Rapid assessment breast clinic: how to offer the same day diagnosis?
The breast journal.18(2):101-2[DOI] 10.1111/j.1524-4741.2012.01225.x.[PMID] 22404049.
2012
Reproducibility of breast biopsy.
European journal of radiology.81 Suppl 1():S95-6[DOI] 10.1016/S0720-048X(12)70038-4.[PMID] 23083620.
2012
The clinical significance of recognizing distinct morphologic features of systemic diseases on breast biopsies.
Advances in anatomic pathology.19(4):217-9[DOI] 10.1097/PAP.0b013e31825c6b58.[PMID] 22692284.
2012
The value of fine needle aspiration biopsy in the diagnosis and prognostic assessment of palpable breast lesions.
Diagnostic cytopathology.40(1):26-34[DOI] 10.1002/dc.21497.[PMID] 22180235.
2012
Why the term 'low-grade ductal carcinoma in situ' should be changed to 'borderline breast disease': diagnostic and clinical implications.
Women's health (London, England).8(1):57-62[DOI] 10.2217/whe.11.88.[PMID] 22171775.
2011
Achieving excellence as a breast health educator at a global level: a new initiative of the World Society for Breast Health.
The breast journal.17(3):221-2[DOI] 10.1111/j.1524-4741.2011.01087.x.[PMID] 21545432.
2011
Borderline breast lesions: diagnostic challenges and clinical implications.
Advances in anatomic pathology.18(3):190-8[DOI] 10.1097/PAP.0b013e31821698cc.[PMID] 21490436.
2011
Breast cancer management in middle-resource countries (MRCs): consensus statement from the Breast Health Global Initiative.
Breast (Edinburgh, Scotland).20 Suppl 2():S12-9[DOI] 10.1016/j.breast.2011.02.015.[PMID] 21388811.
2011
Diagnostic value of imprint cytology during image-guided core biopsy in improving breast health care.
Annals of clinical and laboratory science.41(1):8-13[DOI] .[PMID] 21325248.
2011
The use of fine-needle aspiration biopsy samples for the assessment of basal phenotype in triple negative breast cancer patients: a correlative study.
Diagnostic cytopathology.39(1):1-7[DOI] 10.1002/dc.21312.[PMID] 20091704.
2010
Evidence-based contributions of cytopathology to breast cancer diagnosis and research: how to sustain training and education in breast cytopathology?
The breast journal.16(5):457-9[DOI] 10.1111/j.1524-4741.2010.00972.x.[PMID] 21054643.
2010
How to restore public trust about breast cancer screening? An opportunity to reinforce the need for further advances in science and technology and access to care.
The breast journal.16(1):1-3[DOI] 10.1111/j.1524-4741.2009.00893.x.[PMID] 20465597.
2010
Is it time to retire the term of "in situ carcinoma" and use the term of "borderline breast disease?".
The breast journal.16(6):571-2[DOI] 10.1111/j.1524-4741.2010.01014.x.[PMID] 21070432.
2010
Lobular neoplasia displaying central necrosis: a potential diagnostic pitfall.
Pathology, research and practice.206(8):544-9[DOI] 10.1016/j.prp.2010.02.010.[PMID] 20359832.
2010
Study and management of breast disease.
The breast journal.16 Suppl 1():S1-[DOI] 10.1111/j.1524-4741.2010.00991.x.[PMID] 21050298.
2009
"Early View": a new initiative of the Breast Journal.
The breast journal.15(3):221-2[DOI] 10.1111/j.1524-4741.2009.00734.x.[PMID] 19645774.
2009
Breast cancer risk assessment and follow-up management: is there a magic marker to identify high risk individuals?
The breast journal.15 Suppl 1():S1-[DOI] 10.1111/j.1524-4741.2009.00856.x.[PMID] 19775323.
2009
Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: the utility of immunocytochemical panel in the differential diagnosis.
Diagnostic cytopathology.37(5):324-32[DOI] 10.1002/dc.21006.[PMID] 19191294.
2009
Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel.
Diagnostic cytopathology.37(3):184-90[DOI] 10.1002/dc.20982.[PMID] 19170172.
2009
Ductal lavage is an inefficient method of biomarker measurement in high-risk women.
Cancer prevention research (Philadelphia, Pa.).2(3):265-73[DOI] 10.1158/1940-6207.CAPR-08-0119.[PMID] 19223577.
2009
Implementation of the suggested guidelines for breast cancer risk, genetics, and risk assessment: the critical need for educating practicing physicians.
The breast journal.15(1):1-3[DOI] 10.1111/j.1524-4741.2008.00684.x.[PMID] 19141129.
2009
Lobular carcinoma of the breast with extracellular mucin: new variant of mucin-producing carcinomas?
Pathology international.59(6):405-9[DOI] 10.1111/j.1440-1827.2009.02385.x.[PMID] 19490472.
2009
Papillary thyroid carcinoma with metastasis to the frontal skull.
Diagnostic cytopathology.37(7):522-6[DOI] 10.1002/dc.21070.[PMID] 19459156.
2009
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.
The breast journal.15(1):4-16[DOI] 10.1111/j.1524-4741.2008.00665.x.[PMID] 19141130.
2009
The challenge of apocrine proliferations of the breast: a morphologic approach.
Pathology, research and practice.205(3):155-64[DOI] 10.1016/j.prp.2008.11.010.[PMID] 19147303.
2008
Breast pathology guideline implementation in low- and middle-income countries.
Cancer.113(8 Suppl):2297-304[DOI] 10.1002/cncr.23833.[PMID] 18837021.
2008
Crossing the borders: an international breast health educational initiative--a collaboration between the American Cancer Society and the University of Florida, Jacksonville.
The breast journal.14(1):1-2[DOI] 10.1111/j.1524-4741.2007.00541.x.[PMID] 18186861.
2008
Integration of professionalism and volunteerism in building the foundation of the "International Institute of Breast Pathology" a worldwide collaboration.
The breast journal.14(2):125-7[DOI] 10.1111/j.1524-4741.2008.00565.x.[PMID] 18315689.
2008
Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women.
Breast cancer research and treatment.112(2):327-33[DOI] .[PMID] 18097749.
2008
Significance of patient education and counseling in improving breast healthcare.
Women's health (London, England).4(6):551-5[DOI] 10.2217/17455057.4.6.551.[PMID] 19072456.
2008
Survivorship: a needed program for the continuity of care for breast cancer patients.
The breast journal.14(6):515-6[DOI] 10.1111/j.1524-4741.2008.00640.x.[PMID] 19053999.
2008
The knowledge about risk for breast cancer: the patients' right to know.
The breast journal.14(3):219-20[DOI] 10.1111/j.1524-4741.2008.00589.x.[PMID] 18476881.
2008
The National Accreditation Program for Breast Centers: quality improvement through interdisciplinary evaluation and management.
Bulletin of the American College of Surgeons.93(10):13-7[DOI] .[PMID] 19469362.
2007
Coming together to conquer the fight against breast cancer in countries of limited resources: the challenges and the opportunities.
The breast journal.13(3):223-5[DOI] .[PMID] 17461894.
2007
Diagnostic value of telomerase expression in breast fine-needle aspiration biopsies.
Diagnostic cytopathology.35(10):653-5[DOI] .[PMID] 17854082.
2007
The fine line between competency and quality performance in breast pathology: are we serving our patients right?
The breast journal.13(5):441-2[DOI] .[PMID] 17760663.
2007
Use of imprint cytology for assessment of surgical margins in lumpectomy specimens of breast cancer patients.
Diagnostic cytopathology.35(10):656-9[DOI] .[PMID] 17854083.
2006
An invitation to join the World Society of Breast Health.
The breast journal.12(5 Suppl 2):S123-[DOI] .[PMID] 16958989.
2006
Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.
The breast journal.12 Suppl 1():S3-15[DOI] .[PMID] 16430397.
2006
Breast cancer in limited-resource countries: diagnosis and pathology.
The breast journal.12 Suppl 1():S27-37[DOI] .[PMID] 16430396.
2006
Breast cancer in resource-limited countries.
Women's health (London, England).2(6):797-800[DOI] 10.2217/17455057.2.6.797.[PMID] 19803996.
2006
Papillary carcinoma of the breast in a male patient with a treated prostatic carcinoma diagnosed by fine-needle aspiration biopsy: a case report and review of the literature.
Diagnostic cytopathology.34(3):214-7[DOI] .[PMID] 16548002.
2006
Raising the bar: a plea for standardization and quality improvement in the practice of breast pathology.
The breast journal.12(5):409-12[DOI] .[PMID] 16958956.
2005
Core needle biopsy versus fine needle aspiration biopsy: are there similar sampling and diagnostic issues?
Clinics in laboratory medicine.25(4):679-88, vi[DOI] .[PMID] 16308086.
2005
Cytomorphology as a risk predictor: experience with fine needle aspiration biopsy, nipple fluid aspiration, and ductal lavage.
Clinics in laboratory medicine.25(4):827-43, viii[DOI] .[PMID] 16308095.
2005
Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions.
Clinics in laboratory medicine.25(4):713-31, vi[DOI] .[PMID] 16308088.
2005
Nipple fluid cytology.
Clinics in laboratory medicine.25(4):787-94, vii[DOI] .[PMID] 16308092.
2005
Prognostic/predictive factors in breast cancer.
Clinics in laboratory medicine.25(4):809-25, viii[DOI] .[PMID] 16308094.
2004
Female genital schistosomiasis: case report and review of the literature.
Southern medical journal.97(5):525-7[DOI] .[PMID] 15180032.
2004
Influencing the change: building blocks for integration of care in breast centers.
The breast journal.10(5):381-2[DOI] .[PMID] 15327488.
2004
Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, PA.
Human pathology.35(7):781-4[DOI] .[PMID] 15257539.
2004
Report of the Working Groups on Breast MRI: report of the Breast Cancer Staging Group.
The breast journal.10 Suppl 2():S3-8[DOI] .[PMID] 15330873.
2004
Stromal infiltration as a predictor of tumor invasion in breast fine-needle aspiration biopsy.
Diagnostic cytopathology.30(3):182-6[DOI] .[PMID] 14986299.
2003
Core needle biopsy versus fine-needle aspiration biopsy: are there similar sampling and diagnostic issues?
The breast journal.9(3):145-6[DOI] .[PMID] 12752620.
2003
Diagnosis of breast cancer in countries with limited resources.
The breast journal.9 Suppl 2():S60-6[DOI] .[PMID] 12713498.
2003
Implementation of a minimally invasive breast biopsy program in countries with limited resources.
The breast journal.9 Suppl 2():S81-5[DOI] .[PMID] 12713501.
2003
Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Diagnostic cytopathology.28(6):329-34[DOI] .[PMID] 12768640.
2003
The expanding role of pathologists in the diagnosis and management of breast cancer: Worldwide Excellence in Breast Pathology Program.
The breast journal.9 Suppl 2():S94-7[DOI] .[PMID] 12713504.
2003
Why most women with breast cancer still undergo mastectomy.
The breast journal.9(2):69-70[DOI] .[PMID] 12603376.
2002
A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers.
Clinical cancer research : an official journal of the American Association for Cancer Research.8(10):3105-17[DOI] .[PMID] 12374678.
2002
A subset of breast invasive ductal carcinoma with distinctive cytomorphology, aggressive clinical behavior, and unique immunologic profiles.
Cancer.96(5):294-300[DOI] .[PMID] 12378597.
2002
Prognostic and predictive value of HER2/neu oncogene in breast cancer.
Microscopy research and technique.59(2):102-8[DOI] .[PMID] 12373720.
2002
The clinical significance of recognizing distinct morphologic and biologic features of hereditary breast cancer.
The breast journal.8(2):69-[DOI] .[PMID] 11896749.
2001
Expanding role of breast cytopathology as a risk predictor.
Advances in anatomic pathology.8(5):255-63[DOI] .[PMID] 11556533.
2001
Lipogranuloma.
The breast journal.7(5):363-4[DOI] .[PMID] 11906448.
2001
Papillary carcinoma.
The breast journal.7(1):68-9[DOI] .[PMID] 11348420.
2000
Assessment of Her-2/neu overexpression in primary breast cancers and their metastatic lesions: an immunohistochemical study.
Annals of clinical and laboratory science.30(3):259-65[DOI] .[PMID] 10945565.
2000
Assessment of prognostic factors in breast fine-needle aspirates.
American journal of clinical pathology.113(5 Suppl 1):S84-96[DOI] .[PMID] 11993712.
2000
Breast Cancer Awareness and the Power of Advocacy.
The breast journal.6(5):279-[DOI] .[PMID] 11348381.
2000
Molecular predictive factors for local recurrence and distant metastasis of breast cancer after lumpectomy with postoperative radiation therapy.
Annals of clinical and laboratory science.30(1):33-40[DOI] .[PMID] 10678581.
2000
Response.
The breast journal.6(2):152-[DOI] .[PMID] 11348355.
1999
Breast Health Education: Our Continuous Commitment.
The breast journal.5(5):287-[DOI] .[PMID] 11348303.
1999
Sampling of Nonpalpable Breast Lesions: A Plea for a Multidisciplinary Approach.
The breast journal.5(2):79-80[DOI] .[PMID] 11348264.
1999
The Missing Link: A "Pap Smear" For Early Breast Cancer Detection and Prevention.
The breast journal.5(1):1-2[DOI] .[PMID] 11348248.
1998
Automation in cytology: a survey conducted by the New Technology Task Force, Papanicolaou Society of Cytopathology.
Diagnostic cytopathology.18(1):47-55[DOI] .[PMID] 9451558.
1998
Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
Annals of clinical and laboratory science.28(6):315-23[DOI] .[PMID] 9846198.
1998
Expression of HER-2/neu oncogene in normal, hyperplastic, and malignant endometrium.
Annals of clinical and laboratory science.28(3):138-43[DOI] .[PMID] 9646853.
1998
Nuclear grooves in fine-needle aspiration biopsies of breast lesions: do they have any significance?
Diagnostic cytopathology.18(5):333-7[DOI] .[PMID] 9582567.
1998
Reproducibility of LSI HER-2/neu SpectrumOrange and CEP 17 SpectrumGreen Dual Color deoxyribonucleic acid probe kit. For enumeration of gene amplification in paraffin-embedded specimens: a multicenter clinical validation study.
Annals of clinical and laboratory science.28(4):215-23[DOI] .[PMID] 9715348.
1997
Fat embolism with the use of intraosseous infusion during cardiopulmonary resuscitation.
The American journal of the medical sciences.314(2):73-9[DOI] .[PMID] 9258208.
1997
The prognostic value of HER-2/neu oncogene in cervical cancer.
Annals of clinical and laboratory science.27(6):396-401[DOI] .[PMID] 9433536.
1997
Why women still die from cervical cancer.
The Journal of the Florida Medical Association.84(6):379-83[DOI] .[PMID] 9379163.
1996
Altered expression of alpha-smooth muscle isoactin in Hirschsprung's disease.
Archives of pathology & laboratory medicine.120(3):270-4[DOI] .[PMID] 8629903.
1996
Breast health. Challenges and promises.
The Journal of the Florida Medical Association.83(7):459-65[DOI] .[PMID] 8824086.
1995
Application of immunostaining for muscle specific actin in detection of myoepithelial cells in breast fine-needle aspirates.
Diagnostic cytopathology.13(1):71-4[DOI] .[PMID] 7587880.
1995
Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers.
Surgical oncology clinics of North America.4(4):601-32[DOI] .[PMID] 8535901.
1995
Prognostic factors in breast cancer: use of cytologic preparations.
Diagnostic cytopathology.13(5):388-95[DOI] .[PMID] 8834313.
1994
Prognostic and diagnostic implications of estrogen and progesterone receptor assays in cytology.
Diagnostic cytopathology.10(3):263-7[DOI] .[PMID] 8050334.
1994
Standardization of immunobioassays as surrogate endpoints.
Journal of cellular biochemistry. Supplement.19():28-35[DOI] .[PMID] 7823602.
1994
Unsuspected metastatic renal cell carcinoma diagnosed by fine needle aspiration biopsy. A report of four cases with immunocytochemical contributions.
Acta cytologica.38(4):554-61[DOI] .[PMID] 8042422.
1993
Cytology of malignant schwannoma metastatic to the lung. Report of a case with diagnosis by fine needle aspiration biopsy.
Acta cytologica.37(3):409-12[DOI] .[PMID] 8388612.
1993
Ductal carcinoma in situ of the breast.
Surgery, gynecology & obstetrics.177(4):425-40[DOI] .[PMID] 8211592.
1993
Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix. An immunocytochemical study.
Cancer.72(2):511-8[DOI] .[PMID] 8319181.
1992
Diagnosis of tuberculosis of bone and soft tissue by fine-needle aspiration biopsy.
Diagnostic cytopathology.8(5):451-5[DOI] .[PMID] 1396023.
1992
Estrogen and progesterone receptors in cytology: a comprehensive review.
Diagnostic cytopathology.8(5):475-91[DOI] .[PMID] 1396026.
1992
Expression of steroid hormone receptors in benign hepatic tumors. An immunocytochemical study.
Archives of pathology & laboratory medicine.116(12):1355-9[DOI] .[PMID] 1333749.
1992
Immunocytochemical localization of estrogen and progesterone receptors in imprint preparations of breast carcinomas.
Cancer.70(8):2109-14[DOI] .[PMID] 1327487.
1992
Immunohistochemical differentiation of atypical hyperplasia vs. carcinoma in situ of the breast.
Cancer detection and prevention.16(4):225-35[DOI] .[PMID] 1281040.
1992
Use of monoclonal antibody for assessment of estrogen and progesterone receptors in malignant effusions.
Diagnostic cytopathology.8(2):161-6[DOI] .[PMID] 1568413.
1991
Application of estrogen receptor immunocytochemical assay to aspirates from mammographically guided fine needle biopsy of nonpalpable breast lesions.
Southern medical journal.84(7):857-61[DOI] .[PMID] 1712514.
1991
Cytologic differentiation between proliferative and nonproliferative breast disease in mammographically guided fine-needle aspirates.
Diagnostic cytopathology.7(6):581-90[DOI] .[PMID] 1769286.
1991
Fine needle aspiration cytology of papillary endometrioid carcinoma of the prostate. The grooved nucleus as a cytologic marker.
Acta cytologica.35(4):451-5[DOI] .[PMID] 1718114.
1991
Fluorescent cytochemical detection of estrogen and progesterone receptors in breast fine-needle aspirates.
American journal of clinical pathology.95(1):35-40[DOI] .[PMID] 1987750.
1991
Human papillomavirus in prostatic cancer: no evidence found by in situ DNA hybridization.
Southern medical journal.84(2):235-6[DOI] .[PMID] 1703667.
1991
Immunocytochemical analysis of progesterone receptors in breast cancer.
American journal of clinical pathology.96(1):59-63[DOI] .[PMID] 1712544.
1991
Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival.
The American journal of pathology.139(2):245-50[DOI] .[PMID] 1714241.
1990
Extragenital granuloma inguinale mimicking a soft-tissue neoplasm: a case report and review of the literature.
Human pathology.21(5):559-61[DOI] .[PMID] 1692564.
1990
Potential value of estrogen receptor immunocytochemical assay in formalin-fixed breast tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.3(6):724-8[DOI] .[PMID] 1702213.
1990
Potential value of hormone receptor assay in carcinoma in situ of breast.
American journal of clinical pathology.94(5):533-7[DOI] .[PMID] 2173395.
1990
Potential value of immunoperoxidase technique in assessment of genital herpes.
The Journal of the Florida Medical Association.77(5):516-9[DOI] .[PMID] 2112586.
1990
Prospective evaluation of radiologically directed fine-needle aspiration biopsy of nonpalpable breast lesions.
Cancer.66(7):1480-7[DOI] .[PMID] 2169989.
1989
The potential value of mammographically guided fine-needle aspiration biopsy of nonpalpable breast lesions.
The American surgeon.55(4):226-31[DOI] .[PMID] 2705686.
1989
Use of monoclonal antibody for assessment of estrogen receptor content in fine-needle aspiration biopsy specimen from patients with breast cancer.
Archives of pathology & laboratory medicine.113(1):26-30[DOI] .[PMID] 2462858.
1988
Fine needle aspiration cytology of chondroid syringoma. Report of a case.
Acta cytologica.32(4):482-4[DOI] .[PMID] 2456654.
1988
The potential value of imprint cytology in cytochemical localization of steroid hormone receptors in ovarian cancer.
Diagnostic cytopathology.4(1):42-7[DOI] .[PMID] 3288456.
1988
Use of monoclonal antibodies in immunocytochemical localization of estrogen receptors in ovarian cancer.
Cancer detection and prevention.12(1-6):283-90[DOI] .[PMID] 3052833.

Office Information

Academic Office
1st Floor, Clinical Center
655 West 8th Street, C504
Jacksonville, FL 32209
(904) 244-4387
shahla.masood@jax.ufl.edu
Executive Assistant
Stephanie Crawford
(904) 244-7815
stephanie.crawford@jax.ufl.edu
Administrative Manager
Karen Earick
(904) 244-6069
Karen.Earick@jax.ufl.edu
GME Office
1st Floor, Clinical Center
655 West 8th Street, C504
Jacksonville, FL 32209
Phone: (904) 244-4889
Fax: (904) 244-4060
shahla.masood@jax.ufl.edu
Program Administrator
Rebel Jones
(904) 244-4889
rebel.jones@jax.ufl.edu
Medical Student Office
1st Floor, Clinical Center
655 West 8th Street, C504
Jacksonville, FL 32209
Phone: (904) 244-4889
Fax: (904) 244-4060
shahla.masood@jax.ufl.edu
Clerkship Coordinator
Rebel Jones
(904) 244-4889
rebel.jones@jax.ufl.edu

Education

Medical Degree
1973 · Shiraz University, Shiraz, Iran
Pathology - Anatomic and Clinical Residency
1975 · Jacksonville Health Education Programs (JHEP), Jacksonville, FL, USA
Cytopathology Fellowship
1977 · Jacksonville Health Education Programs (JHEP), Jacksonville, FL, USA